Sailun Biotechnology (688163)
SSE · 688163
Market Cap$4.0B
Revenue$197.7M
Employees330
Listed OnSSE
Ticker688163
CEO / ExecMr. Tiejiong Fan
HeadquartersShanghai
MarketMainland China
Websitewww.serum-china.com.cn
Overview
Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.